Scarica l'app Stockscreener
20.03
1.06%
0.24
Precedente Chiudi:
$19.79
Aprire:
$19.535
Volume 24 ore:
7,109
Relative Volume:
0.08
Capitalizzazione di mercato:
$1.26B
Reddito:
-
Utile/perdita netta:
$-143.59M
Rapporto P/E:
-7.0938
EPS:
-2.8236
Flusso di cassa netto:
$-119.47M
1 W Prestazione:
-0.25%
1M Prestazione:
+13.64%
6M Prestazione:
+13.64%
1 anno Prestazione:
+16.69%
Intervallo 1D:
$19.26
$20.38
Intervallo di 1 settimana:
$19.19
$20.95
Portata 52W:
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
Confronta PHVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
19.92 | 1.26B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.23 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.95 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.04 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
679.74 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.25 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-11 | Iniziato | Guggenheim | Buy |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-09-25 | Iniziato | Wedbush | Outperform |
| 2023-08-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | Iniziato | Bryan Garnier | Buy |
| 2022-09-13 | Ripresa | JMP Securities | Mkt Outperform |
| 2022-08-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-05-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-02 | Iniziato | BofA Securities | Neutral |
| 2021-03-02 | Iniziato | Morgan Stanley | Overweight |
| 2021-03-02 | Iniziato | Oppenheimer | Outperform |
| 2021-03-02 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Pharvaris Nv Borsa (PHVS) Ultime notizie
Will Pharvaris’s (PHVS) Fresh $175M Boost Shift Its Ownership Balance and Strategic Direction? - simplywall.st
When is Pharvaris N.V. stock expected to show significant growthReal Time Guidance From AI Tools - jammulinksnews.com
Is it the right time to buy Pharvaris N.V. stockBest Dividend Data Feed To Watch Now - jammulinksnews.com
Is Pharvaris N.V. a Top Dividend Stock to Watch in 2025Pattern Recognition Based Market Move Prediction - Newser
Does Pharvaris N.V. show high probability of reboundFree Community Shared Smart Money Signals - Newser
What institutional investors are buying Pharvaris N.V. stockRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com
Key resistance and support levels for Pharvaris N.V.Early Entry Ideas with Momentum Potential - Newser
What Fibonacci levels say about Pharvaris N.V. reboundFree Weekly Chart Analysis With Entry Advice - Newser
Pharvaris N.V. Earnings Report Breakdown: What Investors Should KnowEntry Timing Tracker with Alert Accuracy - Newser
Using data tools to time your Pharvaris N.V. exitFree Strong Buy With Technical Confidence - Newser
Pharvaris N.V. stock outlook for YEARAccurate Forecast System with AI Support - Newser
What makes Pharvaris N.V. stock price move sharplyFree Step-by-Step Stock Investment Guide - Newser
Pharvaris N.V. stock momentum explainedTechnical Insight Guide for Safer Trades - Newser
Pharvaris N.V. Uptrend in Early Stages Indicators Say YesDaily Volume Spike Trading Signals Detected - metal.it
Volatility clustering patterns for Pharvaris N.V.High Return Trade Roadmap with Setup Filters - Newser
How Interest Rate Changes Impact Pharvaris N.V. Stock PerformanceFree Risk Controlled Short Term Trade Plans - Newser
Combining machine learning predictions for Pharvaris N.V.AI Stock Movement Forecast with Accuracy - Newser
Why is Pharvaris N.V. stock attracting strong analyst attentionFinancial News Planner Backed By Experts - jammulinksnews.com
Pharvaris N.V. Shows Support at Fibonacci LevelStep-by-Step Trade Signal Implementation Guide Ready - metal.it
What markets is UKOMW expanding into Is Pharvaris N.V. stock a good long term investment optionStock Market Entry Points To Watch Now - jammulinksnews.com
How to integrate Pharvaris N.V. into portfolio analysis tools Short Term Opportunity Finder with Tools - Newser
How strong is Pharvaris N.V. company’s balance sheetUnlock your trading potential today - jammulinksnews.com
What is the risk reward ratio of investing in Pharvaris N.V. stockUnlock daily market insights for better decisions - jammulinksnews.com
What is the dividend policy of Pharvaris N.V. stockConsistently exceptional gains - jammulinksnews.com
Is Pharvaris N.V. a growth stock or a value stockCapitalize on emerging investment opportunities - jammulinksnews.com
What is Pharvaris N.V. company’s growth strategyFree Advanced Stock Screener Access - jammulinksnews.com
Pharvaris Announces US$201.2 Million Public Offering of Shares and Pre-Funded Warrants - Global Legal Chronicle
New Product Launches: Will They Boost Pharvaris N.V. Stock in 2025Free Predictions - metal.it
Pharvaris N.V.'s (NASDAQ:PHVS) 11% loss last week hit both individual investors who own 37% as well as institutions - Yahoo.co
Pharvaris N.V. Stock Performance After Earnings: Historical InsightsFree Access to Community - Newser
How Resilient Is Pharvaris N.V. Stock During Economic DownturnsHigh Return Potential - Newser
What analysts say about Pharvaris N.V. stockRecord-setting profit potential - Autocar Professional
Pharvaris' $201.2M Funding: A Strategic Catalyst for HAE Treatment Innovation and Shareholder Value - AInvest
Pharvaris N.V. Stock Analysis and ForecastDynamic investment opportunities - PrintWeekIndia
How Pharvaris N.V. stock performs during market volatilityFree Short-Term Stock Picks - Newser
How Pharvaris N.V. stock reacts to Fed policy changesRapidly growing investment returns - jammulinksnews.com
Pharvaris Nv Azioni (PHVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.69%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):